|
Daehan New Pharm Co., Ltd. to Hold Regular General Meeting of Shareholders on the 18th
2005.03.18
|
|---|
|
Daehan New Pharm Co., Ltd. held the 21st Regular General Meeting of Shareholders on the 18th at the Hyangnam Pharmaceutical Complex in Hyangnam-myeon, Hwaseong-si, Gyeonggi-do. At the meeting, a cash dividend of 50 KRW (10%) was approved. Additionally, attorney Cho Yeon-ho was appointed as a new outside director, succeeding Dr. Yang Ji-won, who stepped down due to personal reasons. Daehan New Pharm's sales for 2004 reached 42.182 billion KRW, marking a strong growth of 17.4% compared to the previous year. Operating profit increased by 30.7% to 2.569 billion KRW due to sales growth, and ordinary profit rose by 5.7% to 1.463 billion KRW. However, net income for the year decreased by 8.4% to 904.8 million KRW due to an increase in deferred corporate taxes. CEO Park Myung-rae stated, "Daehan New Pharm will continue to maximize sales performance through continuous new product development and proactive customer-centered sales and marketing activities this year. We will also strengthen the accuracy and speed of operations by stabilizing the ERP system, making this year the first year for preparing to enter the 100 billion KRW sales era." |


Home